Inventor · disambiguated record
Andreas Kordikowski
Also filed as: KORDIKOWSKI ANDREAS
13 granted patents·11 pending applications·45 citations·filing 2002–2025
89Inventor score
Top patents by PatentIndex Score
24 records- 0191US11932630B2Heteroaryl aminopropanol derivativesNOVARTIS AG·Filed 2022·Granted Mar 19, 2024·2 cites·20 claims
- 0286US8080236B2Particulate materialsKORDIKOWSKI ANDREAS·Filed 2009·Granted Dec 20, 2011·8 cites·112 claims
- 0383US8470301B2Particulate materialsKORDIKOWSKI ANDREAS·Filed 2011·Granted Jun 25, 2013·5 cites·20 claims
- 0479US8828359B2Particulate materialsKORDIKOWSKI ANDREAS·Filed 2013·Granted Sep 9, 2014·3 cites·20 claims
- 0576US10251881B2Particulate materialsNEKTAR THERAPEUTICS·Filed 2017·Granted Apr 9, 2019·1 cites·24 claims
- 0674US7087197B2Particle formationNEKTAR THERAPEUTICS·Filed 2002·Granted Aug 8, 2006·17 cites·10 claims
- 0773US9616060B2Particulate materialsNEKTAR THERAPEUTICS·Filed 2014·Granted Apr 11, 2017·1 cites·16 claims
- 0872US2024199593A1Novel Heteroaryl Aminopropanol DerivativesNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0971US2024391938A1Crystalline forms of a tlr7/tlr8 inhibitorNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1066US7582284B2Particulate materialsNEKTAR THERAPEUTICS·Filed 2003·Granted Sep 1, 2009·8 cites·62 claims
- 1165US2019175591A1Particulate materialsNEKTAR THERAPEUTICS·Filed 2019·Application pending·0 cites
- 1258US12084460B2Crystalline forms of a TLR7/TLR8 inhibitorNOVARTIS AG·Filed 2019·Granted Sep 10, 2024·0 cites·15 claims
- 1352US11891401B2Solid forms of N-(4-fluoro-3-(6-(3-methylpyridin-2-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)phenyl)-2,4-dimethyloxazole-5-carboxamideNOVARTIS AG·Filed 2019·Granted Feb 6, 2024·0 cites·14 claims
- 1451US11597733B2Compounds and compositions for the treatment of parasitic diseasesNOVARTIS AG·Filed 2020·Granted Mar 7, 2023·0 cites·12 claims
- 1551US2025304538A1Process of preparing remibrutinib substantially free of nitrosamine impurityNOVARTIS AG·Filed 2025·Application pending·0 cites
- 1648US10071973B2Crystalline isoxazole hydroxamic acid compoundsNOVARTIS AG·Filed 2017·Granted Sep 11, 2018·0 cites·15 claims
- 1748US2022194936A1Crystalline forms of n-(5-(5-((1r,2s)-2-fluorocyclopropyl)-1,2,4-oxadiazol-3-yl)-2-methylphenyl)imidazo[1,2-a]pyridine-3-carboxamideNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1847US11993582B2Crystalline forms of a LTA4H inhibitorNOVARTIS AG·Filed 2019·Granted May 28, 2024·0 cites·16 claims
- 1945US2006280823A1Particle formationPALAKODATY SRINIVAS·Filed 2006·Application pending·0 cites
- 2045US2006279011A1Particle formationPALAKODATY SRINIVAS·Filed 2006·Application pending·0 cites
- 2142US2025268895A1Crystalline Forms of a BTK InhibitorNOVARTIS AG·Filed 2020·Application pending·0 cites
- 2239US2006160871A1Stable non-crystalline formulation comprising losartanNEKTAR THERAPEUTICS·Filed 2005·Application pending·0 cites
- 2339US2004028646A1Particle formationFiled 2003·Application pending·0 cites
- 2433US2005085409A1Particle formationFiled 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andreas Kordikowski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →